Revelation Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $37 | $0 |
Gross Profit | -7 | -6 | 31 | -6 |
EBITDA | -2,515 | -1,895 | -2,319 | -2,864 |
EBIT | -2,522 | -1,902 | -2,325 | -2,870 |
Net Income | -8,389 | -2,681 | -2,202 | -2,628 |
Net Change In Cash | 0 | 0 | 37 | 0 |
Free Cash Flow | -2,478 | -2,857 | -2,002 | -1,716 |
Cash | 12,073 | 14,551 | 11,991 | 13,994 |
Basic Shares | 1,635 | 1,089 | 264 | 209 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -25 | -40 | -69 |
EBITDA | -8,631 | -10,839 | -11,933 |
EBIT | -8,656 | -10,879 | -12,002 |
Net Income | -120 | -10,794 | -11,986 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -7,286 | -11,219 | -11,222 |
Cash | 11,991 | 5,252 | 1,274 |
Basic Shares | 228 | 17 | 369 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$5.13 |
2024-03-31 | -$2.46 |
2023-12-31 | -$8.33 |
2023-09-30 | -$0.42 |
